Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 12 EP applications Andrew John Sanderson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 10, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
No opposition filed within time limit
EP14799018

SALMONELLA CONJUGATE VACCINES

IPC classification:
A61P 31/04, A61K 47/48
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
EXAMINATION REQUESTED
EP16184271

VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES

IPC classification:
A61K 9/50, A61K 39/12, A61K 39/00, C12N 15/88, C12N 15/86, A61K 39/245, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16732999

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/112
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18157689

OMV VACCINES

IPC classification:
A61K 39/00, C12P 1/04, A61K 39/116, A61K 39/118, C07K 14/295, C12N 1/20
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18178079

OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP17206566

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 39/00, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP17191981

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 39/39, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18201788

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 47/06, A61K 47/24, A61K 39/00, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP17736908

IMMUNOGENIC COMPOSITIONS

IPC classification:
C12R 1/36, A61K 39/095, A61K 35/74, C12N 9/14, C12N 1/21
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP18201799

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made
EP17816489

nOMV-ANTIGEN CONJUGATES AND USE THEREOF

IPC classification:
A61K 47/69
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature